Sign in
Explore the registryTrack Inclisiran sodium 300 mg's trials

VICTORION-2P

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Inclisiran sodium 300 mgOngoingActive not recruitingPhase 3Open NCT05030428 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…